← Back to Search

Blood Transfusion

Less red blood cell transfusions for Anemia (P-OpTTICCA Trial)

Phase 3
Waitlist Available
Led By Jacques Lacroix
Research Sponsored by St. Justine's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year.
Awards & highlights

P-OpTTICCA Trial Summary

This trial is testing whether it is feasible to do a larger trial on transfusion thresholds in critically-ill children with anemia.

Eligible Conditions
  • Anemia

P-OpTTICCA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Recruitment: consent
Recruitment: enrolment
Recruitment: screening
Secondary outcome measures
Compliance
Data collection
Data entry
+5 more

P-OpTTICCA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Restrictive arm (intervention)Experimental Treatment1 Intervention
Less red blood cell transfusions. The protocol will require that no red blood cell transfusion be given unless the hemoglobin level is below or equal at 70 g per L.
Group II: Standard care arm (comparator)Active Control1 Intervention
Clinical teams will follow their usual transfusion practices.

Find a Location

Who is running the clinical trial?

Hôpital Jeanne de FlandreUNKNOWN
NHS Blood and TransplantOTHER_GOV
14 Previous Clinical Trials
33,305 Total Patients Enrolled
Oxford University Hospitals NHS TrustOTHER
212 Previous Clinical Trials
1,700,809 Total Patients Enrolled
~24 spots leftby Jun 2025